- KALA BIO Inc at HC Wainwright Ophthalmology Virtual Conference - Pre Recorded TranscriptAug 16, 2023
- Kala Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Q2 2022 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 11, 2022$16.4 (-5.75%)Earnings
- Q1 2022 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 16, 2022$37.08 (+8.47%)Earnings
- Q4 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptMar 29, 2022$75 (-14.29%)Earnings
- Q3 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptNov 15, 2021$105 (+1.45%)Earnings
- Q2 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2021$159 (-5.07%)Earnings
- Kala Pharmaceuticals Inc at BofA Securities 2021 Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2021$297.5 (-7.75%)Earnings
- Q4 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptFeb 25, 2021$386.75 (-13.38%)Earnings
- Kala Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Q3 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020$363 (+0.14%)Earnings
- Kala Pharmaceuticals, Inc. - Special Call TranscriptOct 27, 2020
- Kala Pharmaceuticals, Inc. - Special Call TranscriptSep 17, 2020
- Q2 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2020$458.5Earnings
- Kala Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 25, 2020
- Kala Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 13, 2020
- Q1 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2020$592.5 (+1.98%)Earnings
- Kala Pharmaceuticals Inc STRIDE 3 Data Conference Call TranscriptMar 09, 2020
- Q4 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptFeb 12, 2020$313.5 (-1.95%)Earnings
- Kala Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2019$185.5 (-3.39%)Earnings
- Q2 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2019$219 (-13.27%)Earnings
- Kala Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2019$347 (-2.25%)Earnings
- Q4 2018 Kala Pharmaceuticals Inc Earnings Call TranscriptMar 11, 2019Earnings
Q3 2021 Kala Pharmaceuticals Inc Earnings Call Transcript
Good morning, and welcome to Kala Pharmaceuticals conference call to review its third quarter financial results and the acquisition of Combangio. Please note that the slide presentation that was designed to accompany this conference call is available on Kala's website, kalarx.com as well as through the webcast player. (Operator Instructions) As a reminder, this call is being recorded.
I would now like to turn the call over to Jill Steier, Executive Director, Investor Relations and Corporate Communications for Kala Pharmaceuticals. Please proceed.
Thank you, operator, and thank you all for participating in today's call. Earlier today, we issued two press releases: one announcing our third quarter financial results and recent business highlights; and the other announcing our acquisition of Combangio and a fleet asset CMB-012, which we have renamed KPI-012, a novel cell-free secretome therapy currently in clinical development for persistent corneal
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)